Stephan T. Freer
General Atomics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephan T. Freer.
Chemistry & Biology | 1995
Daniel K. Gehlhaar; Gennady M. Verkhivker; Paul A. Rejto; Christopher J. Sherman; David R. Fogel; Lawrence J. Fogel; Stephan T. Freer
BACKGROUND An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been experimentally determined by X-ray crystallography or NMR. For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand. Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space. We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for molecular recognition with an evolutionary programming search technique. RESULTS We have developed an intermolecular energy function that incorporates steric and hydrogen-bonding terms. The parameters in this function were obtained by docking in three different protein systems. The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease. For this molecule, which has nine rotatable bonds, the crystal structure was reproduced within 1.5 A root-mean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation. The energy function correctly evaluates the crystal structure as the global energy minimum. CONCLUSIONS We believe that a solution of the docking problem may be achieved by matching a simple model of molecular recognition with an efficient search procedure. The necessary ingredients of a molecular recognition model include only steric and hydrogen-bond interaction terms. Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand. This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Gennady M. Verkhivker; Djamal Bouzida; Daniel K. Gehlhaar; Paul A. Rejto; Stephan T. Freer; Peter W. Rose
A microscopic study of functional disorder–order folding transitions coupled to binding is performed for the p27 protein, which derives a kinetic advantage from the intrinsically disordered unbound form on binding with the phosphorylated cyclin A-cyclin-dependent kinase 2 (Cdk2) complex. Hierarchy of structural loss during p27 coupled unfolding and unbinding is simulated by using high-temperature Monte Carlo simulations initiated from the crystal structure of the tertiary complex. Subsequent determination of the transition-state ensemble and the proposed atomic picture of the folding mechanism coupled to binding provide a microscopic rationale that reconciles the initiation recruitment of p27 at the cyclin A docking site with the kinetic benefit for a disordered α-helix in the unbound form of p27. The emerging structural polarization in the ensemble of unfolding/unbinding trajectories and in the computationally determined transition-state ensemble is not determined by the intrinsic folding preferences of p27 but rather is attributed to the topological requirements of the native intermolecular interface to order β-hairpin and β-strand of p27 that could be critical for nucleating rapid folding transition coupled to binding. In agreement with the experimental data, the disorder–order folding transition for p27 is largely determined by the functional requirement to form a specific intermolecular interface that ultimately dictates the folding mechanism and overwhelms any local folding preferences for creating a stable α-helix in the p27 structure before overcoming the major free energy barrier.
Proteins | 1996
Gennady M. Verkhivker; Paul A. Rejto; Daniel K. Gehlhaar; Stephan T. Freer
Energy landscapes of molecular recognition are explored by performing “semi‐rigid” docking of FK‐506 and rapamycin with the Fukisawa binding protein (FKBP‐12), and flexible docking simulations of the Ro‐31‐8959 and AG‐1284 inhibitors with HIV‐1 protease by a genetic algorithm. The requirements of a molecular recognition model to meet thermodynamic and kinetic criteria of ligand‐protein docking simultaneously are investigated using a family of simple molecular recognition energy functions. The critical factor that determines the success rate in predicting the structure of ligand‐protein complexes is found to be the roughness of the binding energy landscape, in accordance with a minimal frustration principle. The results suggest that further progress in structure prediction of ligand‐protein complexes can be achieved by designing molecular recognition energy functions that generate binding landscapes with reduced frustration.
International Journal of Quantum Chemistry | 1999
Djamal Bouzida; Paul A. Rejto; Sandra Arthurs; Anthony B. Colson; Stephan T. Freer; Daniel K. Gehlhaar; Veda Larson; Brock A. Luty; Peter W. Rose; Gennady M. Verkhivker
We present the results of molecular docking simulations with HIV-1 protease for the sb203386 and skf107457 inhibitors by Monte Carlo simulated annealing. A simplified piecewise linear energy function, the standard AMBER force field, and the AMBER force field with solvation and a soft-core smoothing component are employed in simulations with a single-protein conformation to determine the relationship between docking simulations with a simple energy function and more realistic force fields. The temperature-dependent binding free energy profiles of the inhibitors interacting with a single protein conformation provide a detailed picture of relative thermodynamic stability and a distribution of ligand binding modes in agreement with experimental crystallographic data. Using the simplified piecewise linear energy function, we also performed Monte Carlo docking simulations with an ensemble of protein conformations employing preferential biased sampling of low-energy protein conformations, and the results are analyzed in connection with the free energy profiles. Q 1999 John Wiley & Sons, Inc. Int J Quant Chem 72: 73)84, 1999
Journal of Molecular Recognition | 1999
Gennady M. Verkhivker; Paul A. Rejto; Djamal Bouzida; Sandra Arthurs; Anthony B. Colson; Stephan T. Freer; Daniel K. Gehlhaar; Veda Larson; Brock A. Luty; Tami Marrone; Peter W. Rose
The thermodynamic and kinetic aspects of molecular recognition for the methotrexate (MTX)–dihydrofolate reductase (DHFR) ligand–protein system are investigated by the binding energy landscape approach. The impact of ‘hot’ and ‘cold’ errors in ligand mutations on the thermodynamic stability of the native MTX–DHFR complex is analyzed, and relationships between the molecular recognition mechanism and the degree of ligand optimization are discussed. The nature and relative stability of intermediates and thermodynamic phases on the ligand–protein association pathway are studied, providing new insights into connections between protein folding and molecular recognition mechanisms, and cooperativity of ligand–protein binding. The results of kinetic docking simulations are rationalized based on the thermodynamic properties determined from equilibrium simulations and the shape of the underlying binding energy landscape. We show how evolutionary ligand selection for a receptor active site can produce well‐optimized ligand–protein systems such as MTX–DHFR complex with the thermodynamically stable native structure and a direct transition mechanism of binding from unbound conformations to the unique native structure. Copyright
Proteins | 2001
Gennady M. Verkhivker; Djamal Bouzida; Daniel K. Gehlhaar; Paul A. Rejto; Lana Schaffer; Sandra Arthurs; Anthony B. Colson; Stephan T. Freer; Veda Larson; Brock A. Luty; Tami Marrone; Peter W. Rose
Computer simulations using the simplified energy function and simulated tempering dynamics have accurately determined the native structure of the pYVPML, SVLpYTAVQPNE, and SPGEpYVNIEF peptides in the complexes with SH2 domains. Structural and equilibrium aspects of the peptide binding with SH2 domains have been studied by generating temperature‐dependent binding free energy landscapes. Once some native peptide–SH2 domain contacts are constrained, the underlying binding free energy profile has the funnel‐like shape that leads to a rapid and consistent acquisition of the native structure. The dominant native topology of the peptide–SH2 domain complexes represents an extended peptide conformation with strong specific interactions in the phosphotyrosine pocket and hydrophobic interactions of the peptide residues C‐terminal to the pTyr group. The topological features of the peptide–protein interface are primarily determined by the thermodynamically stable phosphotyrosyl group. A diversity of structurally different binding orientations has been observed for the amino‐terminal residues to the phosphotyrosine. The dominant native topology for the peptide residues carboxy‐terminal to the phosphotyrosine is tolerant to flexibility in this region of the peptide–SH2 domain interface observed in equilibrium simulations. The energy landscape analysis has revealed a broad, entropically favorable topology of the native binding mode for the bound peptides, which is robust to structural perturbations. This could provide an additional positive mechanism underlying tolerance of the SH2 domains to hydrophobic conservative substitutions in the peptide specificity region. Proteins 2001;45:456–470.
Archive | 1997
Paul A. Rejto; Gennady M. Verkhivker; Daniel K. Gehlhaar; Stephan T. Freer
A number of challenging computational problems arise in the field of structure-based drug design, including the estimation of ligand binding affinity and the de novo design of novel ligands. An important step toward solutions of these problems is the consistent and rapid prediction of the thermodynamically most favorable structure of a ligand—protein complex from the three-dimensional structures of its unbound ligand and protein components. This fundamental problem in molecular recognition is commonly known as the docking problem [1–3]. To solve this problem, two distinct conditions must be satisfied. The first is a thermodynamic requirement: the energy function used to describe ligand—protein binding must have the crystal structure of ligand—protein complexes as its global energy minimum. The second is a kinetic requirement: it must be possible to locate consistently and rapidly the global energy minimum on the ligand—protein binding energy landscape. While the first condition is necessary for successful structure prediction, it is by no means sufficient. Without kinetic accessibility, the global minimum cannot be reached during docking simulations, and computational structure prediction will fail. Here we review approaches to address both the kinetic and thermodynamic aspects of the docking problem.
pacific symposium on biocomputing | 1998
Djamal Bouzida; Sandra Arthurs; Anthony B. Colson; Stephan T. Freer; Daniel K. Gehlhaar; Veda Larson; Brock A. Luty; Paul A. Rejto; Peter W. Rose; Gennady M. Verkhivker
The thermodynamics of ligand-protein molecular recognition is investigated by the energy landscape approach for two systems: methotrexate(MTX)--dihydrofolate reductase(DHFR) and biotin-streptavidin. The temperature-dependent binding free energy profile is determined using the weighted histogram analysis method. Two different force fields are employed in this study: a simplified model of ligand-protein interactions and the AMBER force field with a soft core smoothing component, used to soften the repulsive part of the potential. The results of multiple docking simulations are rationalized from the shape of the binding free energy profile that characterizes the thermodynamics of the binding process.
Journal of Computer-aided Molecular Design | 2000
Gennady M. Verkhivker; Djamal Bouzida; Daniel K. Gehlhaar; Paul A. Rejto; Sandra Arthurs; Anthony B. Colson; Stephan T. Freer; Veda Larson; Brock A. Luty; Tami Marrone; Peter W. Rose
Journal of Medicinal Chemistry | 1995
Daniel K. Gehlhaar; Karl E. Moerder; Dominic A. Zichi; Christopher J. Sherman; Richard C. Ogden; Stephan T. Freer